IMIC(SZ:000516) Sou Hu Cai Jing·2025-11-04 13:33Core Viewpoint - International Medical (000516) has shown a decline in stock price and financial performance, indicating potential challenges in the healthcare service sector [1][3]. Financial Performance - As of November 4, 2025, the stock closed at 4.78 yuan, down 0.42% with a trading volume of 139,000 hands and a transaction amount of 66.53 million yuan [1]. - For the first three quarters of 2025, the company's main revenue was 2.995 billion yuan, a year-on-year decrease of 16.94%, and the net profit attributable to shareholders was -294 million yuan, down 38.45% [3]. - The third quarter alone saw a main revenue of 961 million yuan, a decline of 18.95%, and a net profit of -129 million yuan, a staggering drop of 234.24% [3]. Market Position - The total market value of International Medical is 10.702 billion yuan, ranking 12th in the healthcare service industry, which has an average market value of 19.659 billion yuan [3]. - The company has a net asset value of 3.054 billion yuan, ranking 14th in the industry [3]. - The company's gross margin is 6.59%, significantly lower than the industry average of 35.56%, placing it 41st in the industry ranking [3]. Investment Sentiment - In the last 90 days, two institutions have provided ratings for the stock, with one giving a buy rating and another an increase rating [4].